| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3392340 | Transplant Immunology | 2010 | 5 Pages |
Abstract
Conclusion patients undergoing HLA antibody-incompatible transplantation are at a high risk of rejection but neither sCD30 (unlike in standard transplantation) nor sCD27 was found to be a risk factor. High sCD30 levels measured at 4-6Â weeks post-transplantation was associated with poorer graft function at one year.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rizwan Hamer, Laura Roche, David Smillie, Andrea Harmer, Daniel Mitchell, Guerman Molostvov, For T. Lam, Habib Kashi, Lam Chin Tan, Chris Imray, Simon Fletcher, David Briggs, David Lowe, Daniel Zehnder, Rob Higgins,